A. Redaelli, D. Romano, and A. Marciano, Face and neck revitalization with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients, J Drugs Dermatol, vol.9, pp.466-72, 2010.

M. Shin, J. Lee, S. Lee, and N. Kim, Platelet-Rich Plasma Combined with Fractional Laser Therapy for Skin Rejuvenation, Dermatologic Surgery, vol.38, issue.4, 2012.
DOI : 10.1111/j.1524-4725.2011.02280.x

N. Papanas and E. Maltezos, Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers, Drug Safety, vol.28, issue.6, pp.455-61, 2010.
DOI : 10.2165/11534570-000000000-00000

N. Ziyadeh, D. Fife, A. Walker, G. Wilkinson, and J. Seeger, A Matched Cohort Study of the Risk of Cancer in Users of Becaplermin, Advances in Skin & Wound Care, vol.24, issue.1, pp.31-39, 2011.
DOI : 10.1097/01.ASW.0000392922.30229.b3

M. Kasper, V. Jaks, D. Hohl, and R. Toftgard, Basal cell carcinoma ??? molecular biology and potential new therapies, Journal of Clinical Investigation, vol.122, issue.2, pp.455-63, 2012.
DOI : 10.1172/JCI58779

A. Okawa, Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic genes expression and improve survival rates, Plast Reconstr Surg, vol.129, pp.858-66, 2012.

C. Fingas, S. Bronk, N. Werneburg, J. Mott, M. Guicciardi et al., Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells, Hepatology, vol.11, issue.6, pp.2076-88, 2011.
DOI : 10.1002/hep.24588

J. Xie, M. Aszterbaum, and X. Zhang, A role of PDGFR?? in basal cell carcinoma proliferation, Proceedings of the National Academy of Sciences, vol.98, issue.16, pp.9255-9264, 2001.
DOI : 10.1073/pnas.151173398